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Abstract
Introduction and hypothesis Pelvic organ prolapse (POP) re-
currence after surgery is a major problem. POP that is more
advanced preoperatively is associated with a higher risk of
recurrence postoperatively. We hypothesized that women with
a stage 2 cystocele differ from those with a stage 3 or 4
cystocele. The aim of this study was to compare the baseline
characteristics of women with mild and those with more ad-
vanced cystocele.
Methods Patients had participated in one of two multicenter
prospective cohort studies on women undergoing convention-
al anterior colporrhaphy without previous POP surgery. This
was a secondary analysis of these data. Women with a preop-
erative cystocele stage 2 were compared with women with a
stage 3 or 4 cystocele. Logistic regression models were
employed to calculate odds ratios (OR) and 95% confidence
intervals (CI).
Results Two hundred and sixty-nine women were assessed, of
whom 132 (49.1%) had an advanced cystocele. Only older
age was significantly associated with advanced cystocele pre-
operatively, with an OR of 1.07 (95% CI 1.04–1.10). There
were no significant differences between women with ad-
vanced or stage 2 cystocele in body mass index, vaginal de-
liveries, assisted delivery, positive family history of POP,
concurrent rectocele, concurrent uterine of vaginal vault pro-
lapse, major levator ani muscle defects, or levator hiatal area.
Conclusions Women with advanced cystocele were signifi-
cantly older than women with stage 2 cystocele. This raises
the question whether it would be favorable to perform POP
surgery in an earlier stage, i.e., at a younger age, in order to
prevent POP recurrence.
Keywords Advanced stage . Age . Pelvic organ prolapse .
Recurrence
Introduction
Female pelvic organ prolapse (POP) is a common condition
that can have a great negative impact on women’s social,
physical, and psychological well-being [1]. Women may have
symptoms such as feeling or seeing a bulge in their vagina, or
they may have micturition, defecation, and sexual problems.
The severity of symptoms does not correlate well with the
severity of POP, and many women with POP are asymptom-
atic [2]. In case of symptomatic POP, options include expec-
tant management (pelvic floor exercises, including physical
therapy), pessary treatment, and surgery [3]. The lifetime risk
of surgery for POP in the general female population is 13–
19% [4, 5]. POP recurrence after surgery is a major problem,
with anatomical recurrence rates reported in the literature from
31% up to 59% [6, 7]. Anterior-compartment prolapse, also
referred to as cystocele, is the most commonly affected in POP
and is the most prone for recurrence after surgery [8, 9].
Advanced preoperative stage seems to be an important risk
factor for recurrence [7, 10–13]. In a systematic review on risk
factors, it was the only risk factor associated with recurrence
in at least two cohort or cross-sectional studies with multivar-
iate analysis in a Western country [14]. This raises the
* Tineke F. M. Vergeldt
Tineke.Vergeldt@radboudumc.nl
1 Obstetrics & Gynecology, Radboud University Medical Center,
P.O.Box 9101, 6500 HB Nijmegen, The Netherlands
2 Obstetrics & Gynecology, Maastricht University Medical Center,
Maastricht, The Netherlands
3 Obstetrics & Gynecology, Zuyderland Medical Center,
Heerlen, The Netherlands
Int Urogynecol J (2017) 28:983–987
DOI 10.1007/s00192-016-3216-0
question of whether there is a difference between women with
mild and women with more advanced POP.
We hypothesized that women with a stage 2 cystocele dif-
fer from women with a stage 3 or 4 cystocele. The aim of this
study was to compare baseline characteristics of women with
mild to women with more advanced cystocele.
Materials and methods
Our cohort had participated in one of twomulticenter prospec-
tive cohort studies concerning women undergoing conven-
tional anterior colporrhaphy (i.e., without the use of mesh
materials) performed in nine teaching hospitals in
The Netherlands. This was a secondary analysis of these data.
In the first study, women were assessed between January 2006
and September 2008 for a randomized controlled trial com-
paring indwelling catheterization for 2 versus 5 days follow-
ing surgery [15]. The follow-up visits after 2 years, which
included POP staging and translabial 3D ultrasound (US),
were performed between November 2009 and April 2010.
The aim of that study was to determine whether levator defects
were a risk factor for cystocele recurrence and to identify other
risk factors associated with recurrence [12]. In the second
study, women were recruited from June 2010 until
November 2012, with a follow-up of 1 year. The primary
aim of this study was to assess the diagnostic accuracy of
translabial 3D US in the diagnosis of levator defects in women
with POP, using magnetic resonance imaging (MRI) as refer-
ence test [16, 17]. The protocols of both studies were approved
by the medical ethics committees of each participating hospi-
tal, and all women gave written informed consent before en-
rollment in the study. In both studies, women had undergone
an anterior colporrhaphy without the use of meshmaterials and
without previous POP surgery. Anterior colporrhaphywas per-
formed alone or in combination with other POP procedures.
All women completed a validated questionnaire, with ad-
ditional questions concerning possible risk factors [18]. Pelvic
examination was performed with the patient in the lithotomy
position. POP staging was performed according to the Pelvic
Organ Prolapse Quantification (POP-Q) scoring system in the
second database [19] and according to the Baden-Walker clas-
sification in the first [20], as POP-Q classification was not
generally introduced into daily practice at the time of that
study. For this secondary analysis, only women with Baden-
Walker or POP-Q stage 2 cystocele were included. Advanced
preoperative stage was defined as Baden-Walker or POP-Q
stage 3 or 4, i.e., the most distal part of the prolapse during
Valsalva was bulging out of the vagina according to the
Baden-Walker classification or ≥1 cm from the hymenal rem-
nants according to the POP-Q classification. The procedure of
translabial 3D US and assessment of US finding is described
previously [13].
Women undergoing an anterior colporrhaphy for a stage 2
cystocele were compared with women undergoing the same
procedure for a stage 3 or 4 (advanced) cystocele. Baseline
characteristics investigated were age, body mass index (BMI),
number of vaginal deliveries, having had an assisted vaginal
delivery, positive family history of POP, concurrent rectocele,
concurrent uterine or vaginal-vault prolapse, major levator ani
muscle defects on US, and levator hiatal area during Valsalva
on US. Positive family history of POP was defined as having
(had) amother or sister with POP. Because two databases were
combined, baseline characteristics were calculated for both
databases separately and combined.
We used the statistical software package SPSS version 22.0
(SPSS Inc., Chicago, IL, USA) for statistical analyses.
Logistic regression models were employed to calculate odds
ratios (OR) and 95% confidence intervals (CI). A p value <
0.05 was considered statistically significant.
Results
In this secondary analysis, 269 women with at least Baden-
Walker or POP-Q stage 2 cystocele were included: 157
(50.9%) underwent anterior colporrhaphy for stage 2
cystocele and 132 (49.1%) for stage 3 or 4. Baseline charac-
teristics for the two databases separately and combined are
shown in Table 1. There were no significant differences except
for concurrent uterine of vaginal vault prolapse, which was
more frequent in the first database.
Possible risk factors for advanced cystocele with ORs and
95% CI are shown in Table 2. Only age was significantly
associated with advanced cystocele. There were no significant
differences between women with advanced or with stage 2
cystocele in BMI, number of vaginal deliveries, having under-
gone an assisted delivery, positive family history of POP, con-
current rectocele, concurrent uterine of vaginal vault prolapse,
major levator ani muscle defects, or levator hiatal area during
Valsalva. Because univariate analysis revealed only one sig-
nificant risk factor, multivariate analysis was not contributory.
Discussion
In this study, characteristics of women seeking surgical treat-
ment for stage 3 or 4 cystocele where compared with those
with stage 2 cystocele. Women with advanced cystocele were
significantly older.
The knowledge that more advanced POP has a higher risk
of recurrence after surgery raises the question as to whether it
would be favorable to perform POP surgery at an earlier stage,
i.e., at a younger age, rather than to wait until POP has
progressed to a more advanced stage. Although older age is
a risk factor for primary POP in multiple studies [21–24],
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other studies have challenged the assumption that POP
worsens over time [25–27]. Two cohort studies that investi-
gated the likelihood of POP progression showed high grades
of spontaneous regression [25, 26]. Both studies suggested
that there was little true change in POP severity over time. A
retrospective cohort study to determine the association be-
tween patient age and POP has shown a weak and complex
relationship [27]. There was a positive correlation between
cystocele and age in premenopausal women, but this relation-
ship was reversed after menopause. The authors concluded
that ageing appeared to play only a limited role in POP etiol-
ogy and pathogenesis, contradicting epidemiological studies
showing age to be a risk factor for POP surgery [28]. This
discrepancy may be due to confounders such as symptoms
of bladder or bowel dysfunction that may become more likely
with increasing urogenital atrophy, which increases with age.
Therefore, surgery might generally be performed at an older
age, not because POP has progressed to an advanced stage, but
because of more severe symptoms at that age and the assump-
tion that urogenital symptoms are the result of POP when in
fact atrophy or overactive bladder syndrome may be the case.
Studies investigating the association between age and POP
recurrence show conflicting results, as well [14]. In two stud-
ies with a cutoff at 60 years, younger age was a significant risk
factor for POP recurrence after surgery [7, 10]. In contrast, in
two other studies in which age was a continuous variable and
in one study with a cutoff at 70 years, no significant associa-
tions were found [11, 12, 29]. The association between age
and POP recurrence is thus more complex, with both younger
and older age as risk factors for POP recurrence.
Younger women with POP are often advised to postpone
POP surgery until progression of complaints because of the
high recurrence risk of POP and the risk that multiple surger-
ies will be needed over time; younger women have a longer
life expectancy and therefore more time to develop recurrence.
Results of the study reported here argue whether the advice to
Table 2 Logistic regression analysis
Stage 2 cystocele Stage 3 or 4 cystocele OR (95% CI) P
-value
n n or Mean (% or range) n n or Mean (% or range)
Age (years) 137 55.1 (31–83) 132 61.3 (39–87) 1.07 (1.04–1.10) <0.01
BMI (kg/m2) 119 26.0 (18.4–41.9) 122 26.0 (17.5–35.2) 1.00 (0.93–1.07) 1.00
Vaginal delivery (n) 129 2.3 (0–4) 129 2.3 (0–9) 1.05 (0.83–1.34) 0.67
Assisted delivery (yes/no), n (%) 129 15 (11.6%) 129 16 (12.4%) 1.08 (0.51–2.28) 0.85
Family history of POP (yes/no), n (%) 128 51 (39.8%) 124 58 (46.8%) 1.33 (0.81–2.19) 0.27
Concurrent rectocele (yes/no), n (%) 136 63 (46.3%) 132 52 (39.4%) 0.76 (0.47–1.24) 0.28
Concurrent uterine of vaginal vault prolapse (yes/no), n (%) 137 79 (57.7%) 132 82 (62.1%) 1.20 (0.74–1.96) 0.46
Major levator defect (yes/no), n (%) 133 58 (43.6%) 129 61 (47.3%) 1.16 (0.71–1.89) 0.55
Hiatus during Valsalva (cm2), mean (range) 130 33.0 (16.8–58.5) 126 33.5 (18.9–67.4) 1.01 (0.98–1.04) 0.59
OR odds ratio, CI confidence interval, BMI body mass index, POP pelvic organ prolapse
Table 1 Patient baseline characteristics
Total (n = 269) Weemhoff [12, 15] (n = 130) Notten [16, 17] (n = 139) P
value
n n or mean (% or range) n n or mean (% or range) n n or mean (% or range)
Preoperative stage 3 or 4 (n) 269 132 (49.1%) 130 70 (53.8%) 139 62 (44.6%) 0.13
Age (years) 269 58.1 (31–87) 130 59.0 (39–87) 139 57.4 (31–78) 0.20
BMI (kg/m2) 241 26.0 (17.5–41.9) 125 26.2 (18.4–36.4) 116 25.7 (17.5–41.9) 0.26
Vaginal delivery (mean) 258 2.3 (0–9) 130 2.3 (0–9) 128 2.3 (1–7) 0.65
Assisted delivery (n) 258 31 (12.0%) 130 18 (13.8%) 128 13 (10.2%) 0.36
Family history of POP (n) 252 109 (43.3%) 130 53 (40.8% 122 56 (45.9%) 0.41
Concurrent rectocele (n) 269 115 (42.8%) 130 58 (44.6%) 139 57 (41.0%) 0.55
Concurrent uterine or vaginal vault prolapse (n) 269 161 (59.9%) 130 88 (67.7%) 139 73 (52.5%) 0.01
Major levator defect (n) 262 119 (45.4%) 127 52 (40.9%) 135 67 (49.6%) 0.16
Hiatus during Valsalva (cm2) 256 33.3 (16.8–67.4) 122 32.4 (18.4–56.4) 134 34.0 (16.8–67.4) 0.10
BMI body mass index, POP pelvic organ prolapse
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wait is justified. Theoretically, waiting for progression of com-
plaints could lead to progression of POP due to stretching of
tissue and ligaments. On the other hand, stiffening of vaginal
tissues after menopause could lead to reduction of distensibil-
ity and reduced POP severity. Not every woman with a stage 2
cystocele will develop a stage 3 or 4 cystocele; therefore,
performing surgery in every woman with stage 2 cystocele
would lead to overtreatment. Possibly, pessary use may reduce
the risk of progression to a stage 3 or 4 cystocele due to less
tissue and ligament stretching compared with expectant man-
agement. In a prospective cohort study, no women experi-
enced POP stage worsening with pessary use [30]. However,
the study had a low sample size and short follow-up of 1 year.
Among the possible risk factors investigated in the study pre-
sented here, only age was significantly associated with ad-
vanced cystocele. In future research, it may be interesting to
investigate other factors that may be associated with advanced
POP, such as biomechanical properties of vaginal tissue or
genetic factors.
Strengths of this study are sample size and multicenter
design of the studies combined in one database. There
were no significant differences between the two data-
bases, except for concurrent uterine or vaginal vault pro-
lapse, which was more frequent in the first database. It is
unlikely that this would have influenced our study results,
because recurrence rates were comparable between data-
bases. A weakness of the study is the use of two different
classification systems for POP staging. Since studies that
use either classification system show that advanced POP
preoperatively is a risk factor for POP recurrence after
surgery, the use of the different systems did not influence
our study [7, 10–13]. Because our study population was
mainly Caucasian, these findings cannot be extrapolated to
other ethnicities.
In conclusion, women with advanced POP have a
higher risk of recurrence after POP surgery. Women with
advanced cystocele are significantly older than women
with stage 2 cystocele. Further research is needed to de-
termine whether it would be favorable to perform POP
surgery at an earlier stage (i.e., at a younger age) in order
to prevent POP recurrence.
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